AI‑driven discovery of hidden cancer stem cells
Researchers from SNBNCBS and Ashoka University, led by Dr. Shubhasis Haldar, have created a new AI framework called ACSCeND. The tool can uncover rare cancer stem‑like cells in thousands of patient samples, moving precision oncology closer to reality, especially where advanced laboratory facilities are scarce.
Key developments
- ACSCeND identifies three distinct developmental states – pluripotent‑like, multipotent‑like and unipotent‑like.
- It combines knowledge from high‑resolution single‑cell sequencing with deep‑learning to analyse conventional bulk tumour RNA‑seq data.
- Validated against existing computational methods, ACSCeND consistently outperformed them across independent datasets and sequencing platforms.
- Applied to >25,000 tumour samples from TCGA and PRECOG, revealing clinical impact of stem‑cell states.
Important facts
The analysis showed that tumours enriched with highly potent pluripotent‑like stem cells correlate with poorer patient survival, higher chances of recurrence, and reduced response to modern immunotherapies. The framework also mapped molecular programmes that help these cells evade the immune system, offering new drug‑target opportunities.
The earlier platform OncoMark had already proved AI’s ability to extract complex biological signals from massive genomic datasets. ACSCeND builds on that success by focusing on the most elusive cell population in cancer biology.
UPSC relevance
Understanding ACSCeND’s role helps aspirants link several UPSC themes:
- Science & Technology policy: The project is funded by the Ministry of Science & Technology and the DST, illustrating government support for AI‑driven health research.
- Health sector: Identifying cancer stem cells addresses the challenge of tumour recurrence and drug resistance, a priority in India’s National Cancer Control Programme.
- Innovation & entrepreneurship: Collaboration between a public research institute and a private university showcases the model of academia‑industry partnership encouraged in the Make in India and Digital India initiatives.
Way forward
For policy makers, the next steps could include:
- Scaling ACSCeND to Indian cancer registries to aid early detection and personalized therapy.
- Encouraging open‑source sharing of AI tools to foster wider research participation.
- Integrating AI‑based diagnostics into public health programmes, especially in rural hospitals with limited infrastructure.
Overall, ACSCeND demonstrates how AI can translate massive genomic data into actionable insights, paving the way for precision medicine in India.